Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Colony-stimulating factors. A panel discussion.

W L McGuire1, J Gabrilove, M A Moore

  • 1University of Texas Health Science Center, San Antonio 78284.

Breast Cancer Research and Treatment
|November 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perioperative goal directed therapy: evidence and compliance are two sides of the same coin.

Revista espanola de anestesiologia y reanimacion·2015
Same author

Goal-Directed fluid therapy with closed-loop assistance during moderate risk surgery using noninvasive cardiac output monitoring: A pilot study.

British journal of anaesthesia·2015
Same author

Variability in practice and factors predictive of total crystalloid administration during abdominal surgery: retrospective two-centre analysis.

British journal of anaesthesia·2015
Same author

First closed-loop goal directed fluid therapy during surgery: a pilot study.

Annales francaises d'anesthesie et de reanimation·2014
Same author

Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.

Leukemia·2012
Same author

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2007

Colony-stimulating factors represent a significant advancement in cancer research. These factors offer promising therapeutic potential for various cancers and immunocompromised patients undergoing bone marrow transplantation.

Area of Science:

  • Oncology
  • Hematology
  • Immunology

Background:

  • Recent discoveries in colony-stimulating factors (CSFs) have revolutionized cancer research.
  • CSFs are crucial for regulating the production and function of white blood cells.

Purpose of the Study:

  • To review the current understanding and applications of colony-stimulating factors.
  • To discuss the potential of CSFs in treating various cancers and related conditions.

Main Methods:

  • Expert panel discussion.
  • Review of recent scientific literature.
  • Synthesis of current research findings.

Main Results:

  • Colony-stimulating factors show significant promise in cancer therapy.

Related Experiment Videos

  • Potential applications include treatment for solid tumors, lymphomas, and leukemias.
  • CSFs are also valuable for immunocompromised patients and bone marrow transplant recipients.

    • Conclusions:

    • Colony-stimulating factors are a rapidly advancing field with broad therapeutic implications.
    • Further research and clinical application are expected to expand their role in cancer treatment and supportive care.